Characteristics of multiple sclerosis in the Middle East with special reference to the applicability of international guidelines to the region

References

• Bohlega S. Epidemiology of multiple sclerosis: the Middle East experience. Neurosciences 1997;2:124–26.
   Google Scholar
• Tharakan JJ, Chand RP, Jacob PC. Multiple sclerosis in Oman. Neurosciences (Riyadh) 2005;10:223–5.
   PubMedGoogle Scholar
• Sahraian MA, Khorramnia S, Ebrahim MM, Multiple sclerosis in Iran: a demographic study of 8,000 patients and changes over time. Eur Neurol 2010;64:331–6.
   PubMed Web of Science ®Google Scholar
• Elhami SR, Mohammad K, Sahraian MA, A 20-year incidence trend (1989–2008) and point prevalence (March 20, 2009) of multiple sclerosis in Tehran, Iran: a population-based study. Neuroepidemiology 2011;36:141–7.
   PubMed Web of Science ®Google Scholar
• Saadatnia M, Etemadifar M, Maghzi AH. Multiple sclerosis in Isfahan, Iran. Int Rev Neurobiol 2007;79:357–75.
   PubMed Web of Science ®Google Scholar
• Etemadifar M, Maghzi AH. Sharp increase in the incidence and prevalence of multiple sclerosis in Isfahan, Iran. Mult Scler 2011;17:1022–7.
   PubMed Web of Science ®Google Scholar
• Inshasi J, Thakre M. Prevalence of multiple sclerosis in Dubai, United Arab Emirates. Int J Neurosci 2011;121:393–8.
   PubMed Web of Science ®Google Scholar
• El-Salem K, Al-Shimmery E, Horany K, Multiple sclerosis in Jordan: a clinical and epidemiological study. J Neurol 2006;253:1210–6.
   PubMed Web of Science ®Google Scholar
• al-Din AS, el-Khateeb M, Kurdi A, Multiple sclerosis in Arabs in Jordan. J Neurol Sci 1995;131:144–9.
   PubMed Web of Science ®Google Scholar
• Hamdi TI. Multiple sclerosis in Iraq: a clinical and geomedical survey. J Postgrad Med 1975;21:1–9.
   PubMedGoogle Scholar
• Alshubaili AF, Alramzy K, Ayyad YM, Epidemiology of multiple sclerosis in Kuwait: new trends in incidence and prevalence. Eur Neurol 2005;53:125–31.
   PubMed Web of Science ®Google Scholar
• al-Din AS, Khogali M, Poser CM, Epidemiology of multiple sclerosis in Arabs in Kuwait: a comparative study between Kuwaitis and Palestinians. J Neurol Sci 1990;100: 137–41.
   PubMed Web of Science ®Google Scholar
• Alter M, Kahana E, Zilber N, Multiple sclerosis frequency in Israel's diverse populations. Neurology 2006;66:1061–6.
   PubMed Web of Science ®Google Scholar
• Daif AK, Al-Rajeh S, Awada A, Pattern of presentation of multiple sclerosis in Saudi Arabia: analysis based on clinical and paraclinical features. Eur Neurol 1998;39:182–6.
   PubMed Web of Science ®Google Scholar
• Radhakrishnan K, Ashok PP, Sridharan R, Prevalence and pattern of multiple sclerosis in Benghazi, north-eastern Libya. J Neurol Sci 1985;70:39–46.
   PubMed Web of Science ®Google Scholar
• Deleu D, Mir D, Al Tabouki A, Prevalence, demographics and clinical characteristics of multiple sclerosis in Qatar. Mult Scler 2013;19:816–9.
   PubMed Web of Science ®Google Scholar
• Börü UT, Taşdemir M, Güler N, Prevalence of multiple sclerosis: door-to-door survey in three rural areas of coastal Black Sea regions of Turkey. Neuroepidemiology 2011;37:231–5.
   PubMed Web of Science ®Google Scholar
• Türk Börü U, Alp R, Sur H, Gül L. Prevalence of multiple sclerosis door-to-door survey in Maltepe, Istanbul, Turkey. Neuroepidemiology 2006;27:17–21.
   PubMed Web of Science ®Google Scholar
• Etemadifar M, Abtahi SH. Multiple sclerosis in Isfahan, Iran: past, Present and Future. Int J Prev Med 2012;3:301–2.
   PubMedGoogle Scholar
• Al-Araji A, Mohammed AI. Multiple sclerosis in Iraq: does it have the same features encountered in Western countries? J Neurol Sci 2005 15;234:67–71.
   PubMed Web of Science ®Google Scholar
• Baranzini SE, Nickles D. Genetics of multiple sclerosis: swimming in an ocean of data. Curr Opin Neurol 2012;25: 239–45.
   PubMed Web of Science ®Google Scholar
• Al Jumah M, Al Balwi M, Hussein M, Association of SNPs rs6498169 and rs10984447 with multiple sclerosis in Saudi Patients: a model of the usefulness of familial aggregates in identifying genetic linkage in a multifactorial disease. Mult Scler 2012;18:1395–400.
   PubMed Web of Science ®Google Scholar
• Arababadi MK, Mosavi R, Ravari A, Association of interleukin-4 polymorphisms with multiple sclerosis in southeastern Iranian patients. Ann Saudi Med 2012;32:127–30.
   PubMed Web of Science ®Google Scholar
• Heidari M, Behmanesh M, Sahraian MA. Variation in SNPs of the IL7Ra gene is associated with multiple sclerosis in the Iranian population. Immunol Invest 2011;40:279–89.
   PubMed Web of Science ®Google Scholar
• Azarpira N, Borhani Haghighi A, Pourjafar M, Interleukin 10 gene polymorphism in Iranian patients with multiple sclerosis. Acta Neurol Taiwan 2010;19:107–11.
   PubMedGoogle Scholar
• Al Jumah M, Kojan S, Al Khathaami A, Familial multiple sclerosis: does consanguinity have a role? Mult Scler 2011;17:487–9.
   PubMed Web of Science ®Google Scholar
• Hoppenbrouwers IA. Genetic epidemiological studies of multiple sclerosis (Dissertation). Rotterdam: Erasmus University Press. Available at: http: //repub.eur.nl/pub/22089 (accessed November 2013).
   Google Scholar
• Maghzi AH, Etemadifar M, Shaygannejad V, Conjugal multiple sclerosis in Isfahan, Iran: a population-based study. Mult Scler 2007;13:673–5.
   PubMed Web of Science ®Google Scholar
• Khaki M, Ghazavi A, Ghasami K, Evaluation of viral antibodies in Iranian multiple sclerosis patients. Neurosciences (Riyadh) 2011;16:224–8.
   PubMed Web of Science ®Google Scholar
• Maghzi AH, Etemadifar M, Heshmat-Ghahdarijani K, Cigarette smoking and the risk of multiple sclerosis: a sibling case-control study in Isfahan, Iran. Neuroepidemiology 2011;37:238–42.
   PubMed Web of Science ®Google Scholar
• Yamout B, Itani S, Hourany R, The effect of war stress on multiple sclerosis exacerbations and radiological disease activity. J Neurol Sci 2010;288:42–4.
   PubMed Web of Science ®Google Scholar
• Munger KI, Zhang SM, O'Relly E, Vitamin D intake and incidence of multiple sclerosis. Neurology 2004;62:60–65.
   PubMed Web of Science ®Google Scholar
• Salzer J, Hallmans G, Nystrom M, Vitamin D as a protective factor in multiple sclerosis. Neurology 2012;79:2140–45.
   PubMed Web of Science ®Google Scholar
• Fonesca V, Tongia R, El-Hazmi M. Exposure to sun light and vitamin D deficiency in Saudi Arabian women. Postgrad Med J 1984;60:589–91.
   PubMed Web of Science ®Google Scholar
• Al-Elq A. The status of Vitamin D in medical students in the pre-clerkship years of a Saudi medical school. J Family Community Med 2012;19:100–104.
   PubMedGoogle Scholar
• Al-Shimmery EK, Bzaini AS. Multiple sclerosis in Jordan and Iraq. Clinical and social overview. Neurosciences (Riyadh) 2008;13:276–82.
   PubMed Web of Science ®Google Scholar
• Ashtari F, Shaygannejad V, Farajzadegan Z, Does early-onset multiple sclerosis differ from adult-onset form in Iranian people. J Res Med Sci 2010;15:94–9.
   PubMed Web of Science ®Google Scholar
• El-Salem K, Khader Y. Comparison of the natural history and prognostic features of early onset and adult onset multiple sclerosis in Jordanian population. Clin Neurol Neurosurg 2007;109:32–7.
   PubMed Web of Science ®Google Scholar
• Yamout B, Barada W, Tohme RA, Clinical characteristics of multiple sclerosis in Lebanon. J Neurol Sci 2008;270: 88–93.
   PubMed Web of Science ®Google Scholar
• Hasan ZN, Hasan HA, Sabah AS. Clinical and radiological study of Iraqi multiple sclerosis patients with childhood onset. Neurosciences (Riyadh) 2011;16:229–32.
   PubMed Web of Science ®Google Scholar
• Al-Hamadani HA, Abdalla AS, Al-Saffar AJ. The course of early-onset multiple sclerosis in Iraqi children. World J Pediatr 2012;8:47–51.
   PubMed Web of Science ®Google Scholar
• Yamout B, Itani S, Arabi A, Prognostic factors of multiple sclerosis in Lebanon. Int J Neurosci 2010;120:206–10.
   PubMed Web of Science ®Google Scholar
• Polman CH, Reingold SC, Banwell B, Diagnostic criteria for multiple sclerosis: 2010 revisions to the McDonald criteria. Ann Neurol 2011;69:292–302.
   PubMed Web of Science ®Google Scholar
• Frohman EM, Goodin DS, Calabresi PA, The utility of MRI in suspected MS: report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology. Neurology 2003;61:602–11.
   PubMed Web of Science ®Google Scholar
• National institute for Health and Clinical Excellence. Multiple sclerosis (CG8). Management of multiple sclerosis in primary and secondary care. Available at: http: //publications. nice.org.uk/multiple-sclerosis-cg8 (accessed July 2012).
   Google Scholar
• Goodin DS, Frohman EM, Garmany GP Jr, Disease modifying therapies in multiple sclerosis: report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology and the MS Council for Clinical Practice Guidelines. Neurology 2002;22(58):169–78.
   Google Scholar
• National institute for Health and Clinical Excellence. Technology Appraisal Guidance 127. Natalizumab for the treatment of adults with highly active relapsing–remitting multiple sclerosis. [Internet] August 2007 [cited August 2013] Available at: http: //www.nice.org.uk/guidance/TA127.
   Google Scholar
• National institute for Health and Clinical Excellence. Technology appraisal guidance 254. Fingolimod for the treatment of highly active relapsing–remitting multiple sclerosis. [Internet] April 2012 [cited August 2013]. Available at: http: //guidance.nice.org.uk/TA254.
   Google Scholar
• Gold R, Wolinsky JS, Amato MP, Evolving expectations around early management of multiple sclerosis. Ther Adv Neurol Disord 2010;3:351–67.
   PubMedGoogle Scholar
• Etemadifar M, Janghorbani M, Shaygannejad V. Comparison of interferon beta products and azathioprine in the treatment of relapsing-remitting multiple sclerosis. J Neurol 2007;254:1723–8.
   PubMed Web of Science ®Google Scholar
• Pakdaman H, Sahraian MA, Fallah A, Effect of early interferon beta-1a therapy on conversion to multiple sclerosis in Iranian patients with a first demyelinating event. Acta Neurol Scand 2007;115:429–31.
   PubMed Web of Science ®Google Scholar
• Motamed MR, Najimi N, Fereshtehnejad SM. The effect of interferon-beta1a on relapses and progression of disability in patients with clinically isolated syndromes (CIS) suggestive of multiple sclerosis. Clin Neurol Neurosurg 2007;109: 344–9.
   PubMed Web of Science ®Google Scholar
• Azad A, Taghizadeh G, Khaneghini A. Assessments of the reliability of the Iranian version of the Berg Balance Scale in patients with multiple sclerosis. Acta Neurol Taiwan 2011;20:22–8.
   PubMedGoogle Scholar
• Organisation for Economic Cooperation and Development. Health at a Glance –OECD Indicators 2003. [Internet] [cited August 2013]. Available at: http: //www.oecd-ilibrary.org/social-issues-migration-health/health-at-a-glance-2003_health_glance-2003-en.
   Google Scholar
• World Health Organisation. Medical devices. Country data. [Internet] [cited August 2013]. Available at: http: //www.who.int/ medical_devices/countries/en/.
   Google Scholar
• Yamout BI, Dahdaleh M, Al Jumah MA, Adherence to disease-modifying drugs in patients with multiple sclerosis: a consensus statement from the Middle East MS Advisory Group. Int J Neurosci 2010;120:273–9.
   PubMed Web of Science ®Google Scholar
• Kargarfard M, Etemadifar M, Baker P, Effect of aquatic exercise training on fatigue and health-related quality of life in patients with multiple sclerosis. Arch Phys Med Rehabil 2012;93:1701–8.
   PubMed Web of Science ®Google Scholar
• Ghafari S, Ahmadi F, Nabavi M, Effectiveness of applying progressive muscle relaxation technique on quality of life of patients with multiple sclerosis. J Clin Nurs 2009;18:2171–9.
   PubMed Web of Science ®Google Scholar
• Ayatollahi P, Nafissi S, Eshraghian MR, Impact of depression and disability on quality of life in Iranian patients with multiple sclerosis. Mult Scler 2007;13:275–7.
   PubMedGoogle Scholar
• Kargarfard M, Eetemadifar M, Mehrabi M, Fatigue, depression, and health-related quality of life in patients with multiple sclerosis in Isfahan, Iran. Eur J Neurol 2012;19:431–7.
   PubMed Web of Science ®Google Scholar
• Pakpour AH, Yekaninejad MS, Mohammadi NK, Health-related quality of life in Iranian patients with multiple sclerosis: a cross-cultural study. Neurol Neurochir Pol 2009;43:517–26.
   PubMed Web of Science ®Google Scholar
• Ghaem H, Borhani Haghighi A. The impact of disability, fatigue and sleep quality on the quality of life in multiple sclerosis. Ann Indian Acad Neurol 2008;11:236–41.
   PubMed Web of Science ®Google Scholar
• Al-Tahan AM, Al-Jumah MA, Bohlega SM, The importance of quality-of-life assessment in the management of patients with multiple sclerosis. Recommendations from the Middle East MS Advisory Group. Neurosciences (Riyadh) 2011;16:109–13.
   PubMed Web of Science ®Google Scholar
• El Alaoui Taoussi K, Ait Ben Haddou E, Benomar A, Quality of life and multiple sclerosis: arabic language translation and transcultural adaptation of “MSQOL-54”. Rev Neurol (Paris) 2012;168:444–9.
   PubMed Web of Science ®Google Scholar